Capvizr
News · All summaries
AI & Machine Learning
Bit.bio
Series D$25 million
RoundSeries D
Amount$25 million
LeadBessemer Venture Partners
HQCambridge, United Kingdom
DateNovember 4, 2026
THE DEAL, AT A GLANCE

Bit.bio

From the announcement
Who is involvedBacked by Bessemer Venture Partners, M&G Investments, Dr Jonathan MilnerFrom the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
What happenedBit.bio raised $25M Series D, announced 2026-11-04From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Why it mattersBit.bio's $25M Series D for human cell models is positioned near the middle of tracked Unclassified rounds by size, at the 54th percentile.From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗

Bit.bio · Financing Record

Explore source-linked visual explanations for Bit.bio. Unsupported claims are withheld while source review continues.

Record 15269 · Recorded date: 2026-11-04

Explore company records →
Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime